Moreover, a study reported that downregulated expression of Fxr could repress Shp expression, which in turn could facilitate the expression of SREBP-1c, ACC, and FAS, and then result in the development of NAFLD [24]. Here, FAS is linked to metabolic dysfunction-associated steatotic liver disease.